Bruce protocol: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 22: | Line 22: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
{{stub}} | {{stub}} | ||
== Bruce_protocol == | |||
<gallery> | |||
File:RIAN_archive_555848_Testing_on_treadmill.jpg|Testing on treadmill | |||
</gallery> | |||
Latest revision as of 19:22, 16 March 2025
Bruce Protocol is a diagnostic test used in the evaluation of cardiac function, specifically to evaluate cardiac stress and exercise tolerance. It is a type of treadmill test that follows a standardized protocol of increasing intensity, used to identify possible cardiovascular disease or abnormal heart rhythms during physical exertion.
Overview[edit]
The Bruce Protocol was developed by Dr. Robert A. Bruce in the 1960s. It is a maximal exercise test where the patient is subjected to increasing levels of physical exertion on a treadmill according to a set protocol. The test is used to detect ischemic heart disease and assess the patient's cardiovascular fitness and endurance.
Procedure[edit]
The Bruce Protocol test begins with the patient walking on a treadmill at a slow speed and low gradient. The speed and gradient of the treadmill are increased every three minutes according to the Bruce Protocol's standard schedule. The test continues until the patient reaches their maximum level of exertion, or if the patient experiences chest pain, fatigue, shortness of breath, or other symptoms of angina.
Interpretation[edit]
The results of the Bruce Protocol test are interpreted based on the patient's ability to tolerate exercise. The duration of exercise is correlated with a prediction equation to estimate the patient's VO2 max, which is a measure of the maximum volume of oxygen that an individual can use during intense exercise. The test can also help identify abnormal heart rhythms or ischemic changes.
Risks[edit]
As with any exercise test, there are potential risks associated with the Bruce Protocol. These include the risk of inducing a heart attack or other cardiac event in patients with underlying heart disease. However, the risk is generally low and the test is considered safe for most patients.
